HZNP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Horizon Pharma Inc's quarterly cash and cash equivalents declined from Jun. 2013 ($69.34 Mil) to Sep. 2013 ($58.65 Mil) but then increased from Sep. 2013 ($58.65 Mil) to Dec. 2013 ($80.48 Mil).
Horizon Pharma Inc's annual cash and cash equivalents increased from Dec. 2011 ($17.97 Mil) to Dec. 2012 ($104.09 Mil) but then declined from Dec. 2012 ($104.09 Mil) to Dec. 2013 ($80.48 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Horizon Pharma Inc Annual Data
Horizon Pharma Inc Quarterly Data